Brief: Fusion Pharmaceuticals Announces Q1 2023 Financial Results And Clinical Program Updates
11/05/2023 12:56
May 11 (Reuters) - Fusion Pharmaceuticals Inc FUSN.O :
* FUSION PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2023
FINANCIAL
RESULTS AND CLINICAL PROGRAM UPDATES
* FUSION PHARMACEUTICALS INC - FPI-2265 (AC-PSMA I&T)
PROGRAM
ENROLLING PATIENTS AND ON TRACK FOR Q1 2024 UPDATE
* FUSION PHARMACEUTICALS INC - FPI-1966 PROGRAM TO BE
DISCONTINUED
DUE TO PORTFOLIO PRIORITIZATION DECISION
* FUSION PHARMACEUTICALS INC - $20.0 MILLION PRIVATE
PLACEMENT
FINANCING WITH FEDERATED HERMES KAUFMANN FUNDS EXTENDS CASH
RUNWAY INTO Q2 2025
* FUSION PHARMACEUTICALS INC- QTRLY LOSS PER SHARE $0.45
Source text for Eikon: ID:nPnbFjm3ba
Further company coverage: FUSN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Fusion Pharmaceuticals
See all newsBrief: Acquisition Of Fusion Pharmaceuticals Completed
Brief: Fusion Pharmaceuticals Receives Final Court Order Approving Arrangement
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Brief: Fusion Pharmaceuticals Shareholders Approve Acquisition By Astrazeneca
Fusion Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary